Common biomarkers of idiopathic pulmonary fibrosis and systemic sclerosis
Author Information
Author(s): Ning Shan, Shang Yu, He Yaowu, Wen Zhe, Ning Shangwei, Chen Hong
Primary Institution: Harbin Medical University, Harbin, Heilongjiang Province, China
Hypothesis
The study aims to identify common biomarkers and mechanisms between idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc).
Conclusion
CCL2 was identified as a common biomarker for both IPF and SSc, revealing shared mechanisms and potential treatment directions.
Supporting Evidence
- CCL2 was identified as a common characteristic gene for both IPF and SSc.
- Statistical analyses showed that CCL2 expression was negatively correlated with lung function in IPF patients.
- CCL2 expression decreased after treatment with mycophenolate mofetil in SSc patients.
Takeaway
Researchers found a gene called CCL2 that is important for two lung diseases, helping us understand how they are connected and how to treat them.
Methodology
The study used weighted correlation network analysis (WGCNA), protein-protein interaction analysis, survival analysis, and machine learning methods on datasets from the Gene Expression Omnibus database.
Potential Biases
The study's reliance on existing datasets may introduce biases related to sample selection and data quality.
Limitations
The study relied on public datasets and lacked clinical data, with some datasets having small sample sizes.
Participant Demographics
The study included 176 IPF patients and 113 SSc patients, with a mix of healthy controls.
Statistical Information
P-Value
p=0.0133
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website